<DOC>
	<DOCNO>NCT01722799</DOCNO>
	<brief_summary>Significant lesion small coronary artery frequently find ( 35 % -50 % ) patient coronary artery disease . Independently type coronary angioplasty restenosis need repeat revascularization remain main limitation , represent challenge problem even DES ( drug elute stent ) era . Recently develop drug elute balloon ( DEBs ) , successfully test small series in-stent restenosis , evidence available context small vessel disease . The current study design know , one hand , clinical efficacy Drug elluting balloon IN.PACT FALCON , hand , effectiveness , cost-effectiveness incremental analysis DEBs ( IN.PACT FALCON vs. DES ( RESOLUTE INTEGRITY ) patient de novo lesion small vessel .</brief_summary>
	<brief_title>Randomized Trial Coronary Angioplasty de Novo Lesions sMall vesSElS With Drug Eluting Balloon .</brief_title>
	<detailed_description>Recent study report efficacy local application paclitaxel ® inhibit neointimal proliferation , thus limitation restenosis , lead conception development drug-coated balloon `` Drug Eluting Balloons '' ( DEB ) , release antiproliferative drug time expansion . Initially apply treatment in-stent restenosis . However , DEB may represent therapeutic alternative context anatomo-clinical us always therapeutic percutaneous coronary revascularization stent implantation , case coronary lesion locate small vessel .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>1 . Older 18 , inform consent . 2 . Evidence CAD severe de novo lesion native coronary artery ( ≥70 % stenosis visual estimation &gt; 50 % CT scan ) ; affect 3 . Vessels 2,25 2,75 mm diameter 4 . The length coronary stenosis ≤25 mm 5 . Patient informed consent form sign . 1 . Lesion coronary leave main , 2 . Chronic total occlusion , 3 . Lesions bifurcation , 4 . Severe calcify lesion , 5 . Lesions aortocoronary saphenous vein arterial graft , 6 . Acute Myocardial Infarction 48 hour procedure , 7 . Severe renal dysfunction , 8 . Hypersensibility , allergy contraindication medication : acetylsalicylic acid , clopidogrel , ticlopidine , heparin , paclitaxel , 9 . Allergy contrast medium , 10 . Life expectancy less 1 year , 11 . 1 year FU guarantee , 12 . Being participate another study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>angioplasty</keyword>
	<keyword>Percutaneous Transluminal Coronary Angioplasty</keyword>
	<keyword>Drug elluting Balloon</keyword>
	<keyword>Coronary Balloon</keyword>
	<keyword>Dilatation</keyword>
</DOC>